Searchable abstracts of presentations at key conferences in endocrinology

ea0048wh5 | Workshop H: Miscellaneous endocrine and metabolic disorders | SFEEU2017

A complex case of Von Hippel Lindau syndrome: RCC vs NET metastases?

Fraterrigo Gemma , O'Toole Sam , Plowman Nick , Pushpananthan Suresh , Paraskevopoulos Dimitris , Ang Swee , Drake William

Case history: A 45 year old lady with Von Hippel Lindau syndrome with a complex past medical history presented with symptoms of cauda equina compression. Past medical history includes cerebellar hemangioblastomas, bilateral retinal angiomas, right sided renal cell carcinoma and renal carcinoid tumour treated with partial and then completion nephrectomy, bilateral phaeochromocytoma treated with bilateral adrenalectomy, metastatic neuroendocrine tumour treated with Whipple’...

ea0038p322 | Pituitary | SFEBES2015

Traditional cardiac risk factors in a cohort of hypopituitary patients: a preliminary look at the utility of QRISK2 score

Sivapackianathan Rasheeta , Suriyakumaran Jayani , Akker Scott , Drake William , Waterhouse Mona , Druce Maralyn

Introduction: Increased cardiovascular risk in hypopituitary patients was first documented by Rosen in 1990. Subsequent studies confirmed increased prevalence of cardiovascular and cerebrovascular disease in these patients. The exact mechanism for this is unclear. There is no clear consensus on how best to quantify or predict cardiac risk in hypopituitarism. QRISK2 cardiovascular disease risk algorithm provides estimates of 10-year cardiovascular disease (CVD) risk in patients...

ea0038p323 | Pituitary | SFEBES2015

Long term follow up of patients with craniopharyngioma

Glynn Nigel , Windt Raquel Sanchez , Waterhouse Mona , Akker Scott , Drake William , Druce Maralyn

Introduction: Patients with craniopharyngioma are characterised by a high incidence of hypopituitarism, visual failure and hypothalamic dysfunction. Standardised mortality is markedly elevated and controversy exists about optimal treatment.Aim: We aimed to examine the temporal trends in the treatment of craniopharyngioma at our centre. Also, we sought to examine treatment needs and long-term morbidity in this patient group.Methods:...

ea0038p390 | Steroids | SFEBES2015

Alpha-MSH secretion from a gastro-intestinal stromal tumour leading to ACTH-independent Cushing’s syndrome

Cavlan Dominic , Drake William , Lowry Phil , Bicknell Andrew , Evagora Christopher , King Peter

A 51 year old woman presented with severe Cushing’s syndrome. In addition to a typically Cushingoid appearance she demonstrated increased cutaneous pigmentation in her face and upper chest. Biochemical investigation confirmed elevated serum cortisol levels with loss of circadian variation, and failure to suppress with low dose dexamethasone (0.5 mg 6 hourly for 48 hours). Serum ACTH levels were undetectable. Cross-sectional imaging revealed bilateral macronodular adrenal ...

ea0034p180 | Neoplasia, cancer and late effects | SFEBES2014

Characteristics of ‘foregut’ carcinoid tumours occurring in multiple endocrine neoplasia type 1

Yang Lisa , Mann Kirsty , Winceslaus Julian , Khan Roaid , Akker Scott , Waterhouse Mona , Drake William , Druce Maralyn

Background: The glands most commonly affected in MEN1 are parathyroid, pituitary and pancreas. Pancreatic neuroendocrine tumours (pNETs) are of foregut origin, but a number of other so-called ’foregut carcinoid tumours’ may also occur in MEN1, including tumours of bronchial, thymic, and gastrointestinal origin. Reported rates of prevalence of these latter tumours vary from 2% for thymic and bronchial carcinoids, to 10% for gastric carcinoids. Thymic carcinoids have b...

ea0033p82 | (1) | BSPED2013

The use of Radioactive Iodine in the treatment of childhood and adolescent hyperthyroidism

Meso Muriel , Storr Helen , Allgrove Jeremy , Saccaram Sonali , Newell Margaret , Drake William

Background: Treatment options for Graves’ disease (GD) and multinodular goitre include antithyroid medication, near total thyroidectomy and radioactive iodine (RAI). RAI is an established treatment for GD in the adult population but is used less commonly in children and the adolescent population due to concerns with regards to safety.Methods: A review of a series of 14 adolescent patients receiving RAI between 2007 and 2013 in our department was per...

ea0031p65 | Clinical practice/governance and case reports | SFEBES2013

Peri-operative α-blockade: efficacy of intravenous phenoxybenzamine vs oral phenoxybenzamine in patients with phaeochromocytoma and paraganglioma

Hussain Shazia , Gunganah Kirun , Ashby Michael , Carpenter Robert , Waterhouse Mona , Druce Maralyn , Drake William , Akker Scott

Introduction: Regimens for pre-operative α and β-blockade for patients with secretory phaeochromocytomas/paragangliomas vary widely between centres. The worldwide lack of availability of intravenous phenoxybenzamine (Goldshield) has removed a useful tool in the management of phaeochromocytoma crisis and has necessitated a change in our institution’s routine pre-operative strategy. We compare pre, peri and post-operative surrogate measures of blockade in a cohort...

ea0028p27 | Clinical biochemistry | SFEBES2012

Using the hyperaldosteronism cohort to define normative catecholamine levels for adrenal venous sampling

Sze Wing-Chiu , Matson Matthew , Druce Maralyn , Akker Scott , Chew Shern , Grossman Ashley , Drake William

Objective: (1) To review normative data for catecholamines using our cohort of hyperaldosteronism patients undergoing adrenal vein sampling. This adds to the previously published data of normative values in a cohort of patients with cortisol-producing adenoma. (2) To demonstrate the usefulness of the noradrenaline to adrenaline ratio in the interpretation of adrenal venous sampling results.Design: 38 patients underwent successful, bilateral adrenal venou...

ea0028p77 | Clinical practice/governance and case reports | SFEBES2012

Haemofiltration as a treatment for severe, resistant hypercalcaemia

Pittaway James , Raja Omair , O'Toole Sam , Gunganah Kirun , Srirangalingam Umasuthan , Hanson Philippa , Drake William

Introduction: We describe two patients admitted to our institution with severe hypercalcaemia, resistant to conventional treatment, requiring haemofiltration. Patient 1 was admitted to hospital with profound hypercalcaemia (5.8 mmol/L) secondary to primary hyperparathyroidism (PTH >263 Pmol/L). The hypercalcaemia had been discovered on a surgical admission 3 months previously and was being managed with 0.9% normal saline and pamidronate infusions at an outside hospital. On...

ea0015p91 | Clinical practice/governance and case reports | SFEBES2008

Growth hormone replacement in patients with treated germ cell tumours: safety issues

Chung Teng-Teng LL , Kelly Phillip , Metcalfe Karl , Akker Scott , Drake William , Monson John

The potential for primary tumour relapse is an important consideration during GH replacement therapy (GHR). We report 3 cases of relapse of intra cranial germ cell tumour (GCT) during GHR.Patient 1: An 11 year-old female presenting with visual loss and short stature due to a suprasellar malignant teratoma. She was successfully treated with bleomycin, etoposide and cisplatinum (BEP) and intrathecal chemotherapy. She suffered a first relapse two years late...